Abbott Laboratories Debt to Equity Ratio 2006-2018 | ABT

Current and historical debt to equity ratio values for Abbott Laboratories (ABT) over the last 10 years.
Abbott Laboratories Annual Debt/Equity Ratio
2017 0.90
2016 1.06
2015 0.42
2014 0.36
2013 0.26
2012 0.76
2011 0.63
2010 0.83
2009 0.71
2008 0.71
2007 0.69
2006 0.88
2005 0.46
Abbott Laboratories Quarterly Debt/Equity Ratio
Q2 2018 0.67
Q1 2018 0.69
Q4 2017 0.90
Q3 2017 0.75
Q2 2017 0.76
Q1 2017 0.76
Q4 2016 1.06
Q3 2016 0.41
Q2 2016 0.43
Q1 2016 0.41
Q4 2015 0.42
Q3 2015 0.39
Q2 2015 0.38
Q1 2015 0.41
Q4 2014 0.36
Q3 2014 0.36
Q2 2014 0.31
Q1 2014 0.33
Q4 2013 0.26
Q3 2013 0.35
Q2 2013 0.35
Q1 2013 0.31
Q4 2012 0.76
Q3 2012 0.60
Q2 2012 0.74
Q1 2012 0.65
Q4 2011 0.63
Q3 2011 0.68
Q2 2011 0.69
Q1 2011 0.76
Q4 2010 0.83
Q3 2010 0.87
Q2 2010 0.92
Q1 2010 0.83
Q4 2009 0.71
Q3 2009 0.73
Q2 2009 0.79
Q1 2009 0.88
Q4 2008 0.71
Q3 2008 0.60
Q2 2008 0.79
Q1 2008 0.74
Q4 2007 0.69
Q3 2007 0.78
Q2 2007 0.80
Q1 2007 0.87
Q4 2006 0.88
Q3 2006 0.60
Q2 2006 0.69
Q1 2006 0.44
Q4 2005 0.46
Q3 2005 0.46
Q2 2005 0.40
Q1 2005 0.51
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $112.329B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Stryker (SYK) United States $62.038B 23.97
Boston Scientific (BSX) United States $46.397B 24.14
Baxter (BAX) United States $38.200B 26.00
Zimmer Biomet Holdings (ZBH) United States $24.941B 16.02
Smith & Nephew SNATS (SNN) United Kingdom $15.395B 0.00
ResMed (RMD) United States $15.384B 30.53
Perrigo (PRGO) Ireland $9.565B 13.57
Bio-Rad Laboratories (BIO) United States $9.531B 61.26
Hill-Rom Holdings (HRC) United States $6.308B 21.40
Canopy Growth (CGC) Canada $6.230B 0.00
ICU Medical (ICUI) United States $5.941B 40.56
Haemonetics (HAE) United States $5.156B 47.05
Insulet (PODD) United States $5.134B 0.00
Agios Pharmaceuticals (AGIO) United States $4.432B 0.00
Hutchison China MediTech (HCM) China $4.374B 0.00
Neogen (NEOG) United States $4.327B 68.95
GW Pharmaceuticals (GWPH) United Kingdom $3.748B 0.00
National Vision Holdings (EYE) United States $3.382B 0.00
NuVasive (NUVA) United States $3.320B 31.49
Quidel (QDEL) United States $2.722B 55.76
Phibro Animal Health (PAHC) United States $1.978B 29.37
NxStage Medical (NXTM) United States $1.856B 0.00
Cardiovascular Systems (CSII) United States $1.252B 752.80
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.26
AtriCure (ATRC) United States $1.103B 0.00
VAREX IMAGING (VREX) United States $1.075B 17.57
OraSure Technologies (OSUR) United States $1.025B 67.04
Orthofix (OFIX) United States $1.012B 30.83
TG Therapeutics (TGTX) United States $0.981B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.941B 113.63
MacroGenics (MGNX) United States $0.901B 0.00
Owens & Minor (OMI) United States $0.879B 9.41
Omeros (OMER) United States $0.861B 0.00
LeMaitre Vascular (LMAT) United States $0.706B 33.87
PetIQ (PETQ) United States $0.665B 0.00
Meridian Bioscience (VIVO) United States $0.636B 21.74
Insys Therapeutics (INSY) United States $0.554B 0.00
Evolus (EOLS) United States $0.554B 0.00
Lantheus Holdings (LNTH) United States $0.502B 15.60
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
Utah Medical Products (UTMD) United States $0.340B 21.90
BioLife Solutions (BLFS) United States $0.325B 0.00
Quanterix (QTRX) United States $0.323B 0.00
Surface Oncology (SURF) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.244B 0.00
Chimerix (CMRX) United States $0.210B 0.00
Fonar (FONR) United States $0.169B 10.25
Chembio Diagnostics (CEMI) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.122B 0.00
Female Health (VERU) United States $0.117B 0.00
Trinity Biotech (TRIB) Ireland $0.093B 27.88
United-Guardian (UG) United States $0.086B 18.95
Oramed Pharmaceuticals (ORMP) Israel $0.083B 0.00
CAS Medical Systems (CASM) United States $0.077B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.065B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.026B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00